Asked about the strategic priorities in the US, he added: “Not only the US, but we have interest in selling innovative medicines globally… for emerging markets we are looking at tuck-ins or smaller acquisitions which we can look at integrating with our existing business to get scale in the emerging markets.” Shanghvi added.
Sebi to revamp short-selling, securities lending rules
Sebi is reviewing short-selling and securities lending rules to improve liquidity and price discovery. The regulator is also planning reforms in clearing, broker compliance, custodial
October 25, 2026